[Anemias in preschool children: diagnosis, treatment and evaluation, Recife-PE, Brazil]

S de A Romani1, P I de Lira, M Batista Filho

  • 1Centro da Ciencias da Sáude, Universidade Federal de Pernambuco, Recife, PE, Brasil.

Insights

Iron deficiency anemia is common in young Brazilian children, particularly those under two. Treatment with ferrous sulfate and mebendazole significantly improved hemoglobin levels in affected children.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Public Health

Background:

  • Anemia is a significant health concern in young children globally.
  • Iron deficiency anemia (IDA) is particularly prevalent in preschool-aged children in developing countries.
  • Understanding anemia's prevalence and treatment effects is crucial for public health interventions.

Purpose of the Study:

  • To assess the diagnosis and treatment outcomes of anemia in preschool children.
  • To identify factors associated with anemia prevalence in this age group.
  • To contribute data for a national program combating iron deficiency anemia.

Main Methods:

  • A cross-sectional study of 1,161 preschool children (6-71 months) in Recife, Pernambuco, Brazil.
  • Hemoglobin levels measured using Hainline method; anemia diagnosed using WHO criteria.
  • Children with anemia treated with ferrous sulfate and mebendazole; outcomes analyzed based on age, nutritional status, and family income.

Main Results:

  • Anemia prevalence was highest in children aged 2 years.
  • Significant associations found between anemia and nutritional status (p<0.01) and family income (p<0.01).
  • Post-treatment, 40% of anemic children normalized hemoglobin; mean levels increased significantly (9.11 to 10.3 g/dl, p<0.001).

Conclusions:

  • Anemia is highly prevalent in young Brazilian children, linked to nutritional status and socioeconomic factors.
  • Ferrous sulfate and mebendazole treatment effectively improved hemoglobin levels.
  • Findings support the development of national strategies to combat childhood anemia.